Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ABUS stock: Arbutus Biopharma Corp

Current Rating
Sell

Previous Rating

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$11.55
Market Cap
400M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
3.53
P/S
33.78
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-51.1K
FCF
-1.0
Op. Margin
-929.20%
Net Margin
-726.50%
ROE
-58.60%
ROI
-72.50%
ROA
-34.50%
EPS Growth
84.90%
Current Ratio
8.9
Debt/Equity
9.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Hooper Holmes, Inc. (HPHW) $0.06 - - 1.7M Strong Buy
NeoGenomics, Inc. (NEO) $14.12 - - 1.1B Strong Buy
Kalvista Pharmaceuticals Inc (KALV) $8.70 - - 87.7M Strong Buy
Opiant Pharmaceuticals Inc (OPNT) $15.25 - - 40.1M Strong Buy
Neurometrix Inc (NURO) $1.27 - - 9.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More